EUVIMEDEUVIMED entdecken
Crossref

Construction of a 89 Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors

Xingguo Hou, Lulin Yang, Futao Liu, Feng Wang, Song Liu, Yuan Yao, Zilei Wang, Changsong Qi, Hua Zhu iD, Zhi Yang iD

Molecular Pharmaceutics · 01.06.2026 · 23 (6) · 3458-3467

DOI: 10.1021/acs.molpharmaceut.6c00244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 12.05.2026. Verfasst von Xingguo Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radio…. Hauptthemen laut MEDLINE: Zirconium, Radioisotopes, GPI-Linked Proteins, Neoplasms. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Youth Research Talent Training Program of Peking University Cancer Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZirconiumRadioisotopesGPI-Linked ProteinsNeoplasmsMesothelinAnimalsHumansMiceCell Line, TumorPositron-Emission TomographyAntibodies, MonoclonalTissue DistributionFemaleSingle-Chain AntibodiesRadiopharmaceuticals

Stichwörter der Autor:innen

chimeric antigen receptor T cell therapycolon cancermesothelinpositron emission tomographyzirconium isotope

Substanzen

MesothelinZirconiumZirconium-89RadioisotopesMSLN protein, humanGPI-Linked ProteinsMsln protein, mouseAntibodies, MonoclonalSingle-Chain AntibodiesRadiopharmaceuticals

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department…
  • School of Medicine, Xiamen University, Xiamen 361101, China.
  • Department of Early Drug Development, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Ho…
  • Institute of Biomedical Engineering, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China.

ORCID-Profile: Hua Zhu, Zhi Yang

Förderung

  • Youth Research Talent Training Program of Peking University Cancer Hospital

Zitieren

APA

Hou, X., Yang, L., Liu, F., Wang, F., Liu, S., Yao, Y., Wang, Z., Qi, C., Zhu, H., & Yang, Z. (2026). Construction of a 89 Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors. Molecular Pharmaceutics, 23(6), 3458-3467. https://doi.org/10.1021/acs.molpharmaceut.6c00244

Vancouver

Hou X, Yang L, Liu F, Wang F, Liu S, Yao Y, et al. Construction of a 89 Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors. Molecular Pharmaceutics. 2026;23(6):3458-3467. doi:10.1021/acs.molpharmaceut.6c00244

BibTeX
@article{Hou2026,
  author = {Hou, Xingguo and Yang, Lulin and Liu, Futao and Wang, Feng and Liu, Song and Yao, Yuan and Wang, Zilei and Qi, Changsong and Zhu, Hua and Yang, Zhi},
  title = {Construction of a 89 Zr-Labeled Specific Antibody Fragment for the Noninvasive Detection of Mesothelin-Overexpressing Tumors},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {6},
  pages = {3458--3467},
  doi = {10.1021/acs.molpharmaceut.6c00244}
}
Kostenlos starten →